Patients’ drug costs surge for some neurologic conditions
(Reuters Health) – Many patients with neurologic disorders like multiple sclerosis, epilepsy and Parkinson’s disease have seen steep increases in their out-of-pocket costs for drugs in recent years, a U.S.…